Literature DB >> 2987069

Clonal variants of differentiated P19 embryonal carcinoma cells exhibit epidermal growth factor receptor kinase activity.

C L Mummery, A Feijen, P T van der Saag, C E van den Brink, S W de Laat.   

Abstract

Differentiated clonal cell lines were isolated from pluripotent P19 embryonal carcinoma (EC) cells treated as aggregates with retinoic acid. Two were characterized in detail. The lines differ in morphology, proliferation rate, the production of plasminogen activator, and in their mitogenic response to insulin but both produce extracellular matrix proteins and can be serially passaged over extended periods, in contrast to differentiated derivatives of many other EC lines. Further, both lines have receptors for and respond mitogenically to epidermal growth factor (EGF). Endogenous phosphorylation of several proteins, including the EGF receptor (150 kDa) and a 38-kDa protein, is induced by EGF in membranes isolated from these cells. Preincubation of membranes with EGF renders them able to catalyze phosphorylation of tyrosine residues in exogenously added peptide substrates. High voltage electrophoresis confirmed the tyrosine specificity of the phosphorylation on the 150- and 38-kDa bands. By contrast, similar experiments in undifferentiated cells showed that intact P19 EC neither bind nor respond to EGF mitogenically and EGF induces no changes in phosphorylation in isolated membranes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987069     DOI: 10.1016/0012-1606(85)90466-x

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  19 in total

1.  p300 is involved in formation of the TBP-TFIIA-containing basal transcription complex, TAC.

Authors:  Dimitra J Mitsiou; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

2.  Regulation of Oct-4 gene expression during differentiation of EC cells.

Authors:  J Schoorlemmer; L Jonk; S Sanbing; A van Puijenbroek; A Feijen; W Kruijer
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

3.  Induction of cardiomyogenesis in human embryonic stem cells by human embryonic stem cell-derived definitive endoderm.

Authors:  Jordan R Van Orman; Karim Si-Tayeb; Stephen A Duncan; John Lough
Journal:  Stem Cells Dev       Date:  2011-08-10       Impact factor: 3.272

4.  High chemotactic response to platelet-derived growth factor of a teratocarcinoma differentiated mesodermal cell line.

Authors:  C Liapi; F Raynaud; W B Anderson; D Evain-Brion
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

5.  Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.

Authors:  R P de Groot; J Schoorlemmer; S T van Genesen; W Kruijer
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

6.  Cardiomyocyte differentiation of mouse and human embryonic stem cells.

Authors:  C Mummery; D Ward; C E van den Brink; S D Bird; P A Doevendans; T Opthof; A Brutel de la Riviere; L Tertoolen; M van der Heyden; M Pera
Journal:  J Anat       Date:  2002-03       Impact factor: 2.610

7.  Histone H1(0) mRNA and protein accumulate early during retinoic acid induced differentiation of synchronized embryonal carcinoma cells.

Authors:  F J van Hemert; L J Jonk; O H Destrée
Journal:  Mol Biol Rep       Date:  1992-02       Impact factor: 2.316

8.  A comparative analysis of extra-embryonic endoderm cell lines.

Authors:  Kemar Brown; Stephanie Legros; Jérôme Artus; Michael Xavier Doss; Raya Khanin; Anna-Katerina Hadjantonakis; Ann Foley
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

9.  Characterization of a negative retinoic acid response element in the murine Oct4 promoter.

Authors:  J Schoorlemmer; A van Puijenbroek; M van Den Eijnden; L Jonk; C Pals; W Kruijer
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

10.  Translation initiation on the insulin-like growth factor II leader 1 is developmentally regulated.

Authors:  H Teerink; M A Kasperaitis; C H De Moor; H O Voorma; A A Thomas
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.